Sorna et al. identified a new N’-(1-phenylethyl)-benzohydrazide series by high-throughput virtual screening, compound 12, which was a potent, specific, and reversible inhibitor of KDM1A and suppressed CRC cell proliferation and survival [180]. This evidence concerns the gene KDM1A and colorectal carcinoma.